GenomeNet

Database: UniProt
Entry: P78504
LinkDB: P78504
Original site: P78504 
ID   JAG1_HUMAN              Reviewed;        1218 AA.
AC   P78504; A0AV43; B4DYR1; E9PCF9; O14902; O15122; Q15816;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 3.
DT   29-SEP-2021, entry version 221.
DE   RecName: Full=Protein jagged-1;
DE            Short=Jagged1;
DE            Short=hJ1;
DE   AltName: CD_antigen=CD339;
DE   Flags: Precursor;
GN   Name=JAG1; Synonyms=JAGL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9268641; DOI=10.1006/geno.1997.4820;
RA   Oda T., Elkahloun A.G., Meltzer P.S., Chandrasekharappa S.C.;
RT   "Identification and cloning of the human homolog (JAG1) of the rat Jagged1
RT   gene from the Alagille syndrome critical region at 20p12.";
RL   Genomics 43:376-379(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN ALGS1, AND VARIANT
RP   ALGS1 CYS-184.
RC   TISSUE=Bone marrow;
RX   PubMed=9207788; DOI=10.1038/ng0797-243;
RA   Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M.,
RA   Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E.M., Rand E.B.,
RA   Piccoli D.A., Hood L., Spinner N.B.;
RT   "Alagille syndrome is caused by mutations in human Jagged1, which encodes a
RT   ligand for Notch1.";
RL   Nat. Genet. 16:243-251(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9462510; DOI=10.1016/s1074-7613(00)80457-4;
RA   Li L., Milner L.A., Deng Y., Iwata M., Banta A.B., Graf L., Marcovina S.,
RA   Friedman C., Trask B.J., Hood L., Torok-Storb B.;
RT   "The human homolog of rat Jagged1 expressed by marrow stroma inhibits
RT   differentiation of 32D cells through interaction with Notch1.";
RL   Immunity 8:43-55(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10329626; DOI=10.1093/emboj/18.10.2803;
RA   Bash J., Zong W.-X., Banga S., Rivera A., Ballard D.W., Ron Y., Gelinas C.;
RT   "Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the
RT   expression of Jagged1, a ligand for Notch receptors.";
RL   EMBO J. 18:2803-2811(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10079256; DOI=10.1016/s0002-9440(10)65325-4;
RA   Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.-L., Banks A.,
RA   Leiman J., Ward D., Ish-Horowitz D., Artavanis-Tsakonas S.;
RT   "Human ligands of the Notch receptor.";
RL   Am. J. Pathol. 154:785-794(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-1218 (ISOFORM 1).
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=8955070; DOI=10.1074/jbc.271.51.32499;
RA   Zimrin A.B., Pepper M.S., McMahon G.A., Nguyen F., Montesano R., Maciag T.;
RT   "An antisense oligonucleotide to the notch ligand Jagged enhances
RT   fibroblast growth factor-induced angiogenesis in vitro.";
RL   J. Biol. Chem. 271:32499-32502(1996).
RN   [10]
RP   DISEASE.
RX   PubMed=9207787; DOI=10.1038/ng0797-235;
RA   Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A.,
RA   Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S.,
RA   Chandrasekharappa S.C.;
RT   "Mutations in the human Jagged1 gene are responsible for Alagille
RT   syndrome.";
RL   Nat. Genet. 16:235-242(1997).
RN   [11]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=10978356; DOI=10.1136/jmg.37.9.658;
RA   Jones E.A., Clement-Jones M., Wilson D.I.;
RT   "JAGGED1 expression in human embryos: correlation with the Alagille
RT   syndrome phenotype.";
RL   J. Med. Genet. 37:658-662(2000).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 185-335, FUNCTION, INTERACTION
RP   WITH NOTCH1, DOMAIN, MUTAGENESIS OF PHE-207, AND DISULFIDE BONDS.
RX   PubMed=18660822; DOI=10.1038/nsmb.1457;
RA   Cordle J., Johnson S., Tay J.Z., Roversi P., Wilkin M.B., de Madrid B.H.,
RA   Shimizu H., Jensen S., Whiteman P., Jin B., Redfield C., Baron M.,
RA   Lea S.M., Handford P.A.;
RT   "A conserved face of the Jagged/Serrate DSL domain is involved in Notch
RT   trans-activation and cis-inhibition.";
RL   Nat. Struct. Mol. Biol. 15:849-857(2008).
RN   [14]
RP   STRUCTURE BY NMR OF 252-295, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=19586525; DOI=10.1186/1472-6807-9-43;
RA   Pintar A., Guarnaccia C., Dhir S., Pongor S.;
RT   "Exon 6 of human JAG1 encodes a conserved structural unit.";
RL   BMC Struct. Biol. 9:43-43(2009).
RN   [15]
RP   VARIANTS ALGS1 CYS-184 AND HIS-184.
RX   PubMed=9585603; DOI=10.1086/301875;
RA   Krantz I.D., Colliton R.P., Genin A., Rand E.B., Li L., Piccoli D.A.,
RA   Spinner N.B.;
RT   "Spectrum and frequency of Jagged1 (JAG1) mutations in Alagille syndrome
RT   patients and their families.";
RL   Am. J. Hum. Genet. 62:1361-1369(1998).
RN   [16]
RP   VARIANTS ALGS1 HIS-79; THR-127; ARG-129; LEU-163; GLY-184; SER-187;
RP   GLY-229; PHE-284; CYS-288; PHE-438; SER-731 AND ARG-740.
RX   PubMed=10220506; DOI=10.1016/s0016-5085(99)70017-x;
RA   Crosnier C., Driancourt C., Raynaud N., Dhorne-Pollet S., Pollet N.,
RA   Bernard O., Hadchouel M., Meunier-Rotival M.;
RT   "Mutations in JAGGED1 gene are predominantly sporadic in Alagille
RT   syndrome.";
RL   Gastroenterology 116:1141-1148(1999).
RN   [17]
RP   VARIANTS ALGS1 THR-152 AND LEU-184.
RX   PubMed=10533065;
RX   DOI=10.1002/(sici)1098-1004(199911)14:5<394::aid-humu5>3.0.co;2-1;
RA   Pilia G., Uda M., Macis D., Frau F., Crisponi L., Balli F., Barbera C.,
RA   Colombo C., Frediani T., Gatti R., Iorio R., Marazzi M.G., Marcellini M.,
RA   Musumeci S., Nebbia G., Vajro P., Ruffa G., Zancan L., Cao A.,
RA   DeVirgilis S.;
RT   "Jagged-1 mutation analysis in Italian Alagille syndrome patients.";
RL   Hum. Mutat. 14:394-400(1999).
RN   [18]
RP   VARIANTS ALGS1 TYR-229 AND ARG-386.
RX   PubMed=11058898;
RX   DOI=10.1002/1098-1004(200011)16:5<408::aid-humu5>3.0.co;2-9;
RA   Heritage M.L., MacMillan J.C., Colliton R.P., Genin A., Spinner N.B.,
RA   Anderson G.J.;
RT   "Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome
RT   population.";
RL   Hum. Mutat. 16:408-416(2000).
RN   [19]
RP   VARIANT TOF ASP-274.
RX   PubMed=11152664; DOI=10.1093/hmg/10.2.163;
RA   Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R.,
RA   Dietz H.C.;
RT   "Familial tetralogy of Fallot caused by mutation in the Jagged1 gene.";
RL   Hum. Mol. Genet. 10:163-169(2001).
RN   [20]
RP   VARIANT ALGS1 SER-37.
RX   PubMed=11157803; DOI=10.1093/hmg/10.4.405;
RA   Morrissette J.J.D., Colliton R.P., Spinner N.B.;
RT   "Defective intracellular transport and processing of JAG1 missense
RT   mutations in Alagille syndrome.";
RL   Hum. Mol. Genet. 10:405-413(2001).
RN   [21]
RP   VARIANTS ALGS1 PHE-220 AND ARG-753.
RX   PubMed=11139247; DOI=10.1002/1098-1004(2001)17:1<72::aid-humu11>3.0.co;2-u;
RA   Crosnier C., Driancourt C., Raynaud N., Hadchouel M., Meunier-Rotival M.;
RT   "Fifteen novel mutations in the JAGGED1 gene of patients with Alagille
RT   syndrome.";
RL   Hum. Mutat. 17:72-73(2001).
RN   [22]
RP   VARIANTS ALGS1 ASP-33; SER-37; SER-78; ASN-181; TYR-714 AND SER-902.
RX   PubMed=11180599;
RX   DOI=10.1002/1098-1004(200102)17:2<151::aid-humu8>3.0.co;2-t;
RA   Colliton R.P., Bason L., Lu F.-M., Piccoli D.A., Krantz I.D., Spinner N.B.;
RT   "Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.";
RL   Hum. Mutat. 17:151-152(2001).
RN   [23]
RP   INVOLVEMENT IN DCHE, AND VARIANT DCHE TYR-234.
RX   PubMed=12022040; DOI=10.1086/341327;
RA   Le Caignec C., Lefevre M., Schott J.J., Chaventre A., Gayet M., Calais C.,
RA   Moisan J.P.;
RT   "Familial deafness, congenital heart defects, and posterior embryotoxon
RT   caused by cysteine substitution in the first epidermal-growth-factor-like
RT   domain of Jagged 1.";
RL   Am. J. Hum. Genet. 71:180-186(2002).
RN   [24]
RP   VARIANTS BILIARY ATRESIA LEU-45; ASP-53; MET-65; LYS-203; ASP-690; ARG-871;
RP   GLN-908; PRO-921 AND GLN-1213.
RX   PubMed=12297837; DOI=10.1053/jhep.2002.35820;
RA   Kohsaka T., Yuan Z.-R., Guo S.-X., Tagawa M., Nakamura A., Nakano M.,
RA   Kawasasaki H., Inomata Y., Tanaka K., Miyauchi J.;
RT   "The significance of human Jagged 1 mutations detected in severe cases of
RT   extrahepatic biliary atresia.";
RL   Hepatology 36:904-912(2002).
RN   [25]
RP   VARIANTS ALGS1 SER-39; HIS-184 AND ARG-913.
RX   PubMed=12442286; DOI=10.1002/humu.9095;
RA   Heritage M.L., MacMillan J.C., Anderson G.J.;
RT   "DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations in
RT   Australian Alagille syndrome patients.";
RL   Hum. Mutat. 20:481-481(2002).
RN   [26]
RP   CHARACTERIZATION OF VARIANT ASP-274.
RX   PubMed=12649809; DOI=10.1086/374386;
RA   Lu F., Morrissette J.J.D., Spinner N.B.;
RT   "Conditional JAG1 mutation shows the developing heart is more sensitive
RT   than developing liver to JAG1 dosage.";
RL   Am. J. Hum. Genet. 72:1065-1070(2003).
RN   [27]
RP   VARIANTS ALGS1 VAL-31; PRO-40; SER-75; SER-123; ARG-163; CYS-224 AND
RP   LEU-269, AND VARIANT GLN-937.
RX   PubMed=12497640; DOI=10.1002/humu.9102;
RA   Roepke A., Kujat A., Graeber M., Giannakudis J., Hansmann I.;
RT   "Identification of 36 novel Jagged1 (JAG1) mutations in patients with
RT   Alagille syndrome.";
RL   Hum. Mutat. 21:100-100(2003).
RN   [28]
RP   VARIANTS ALGS1 ASN-120 AND TYR-187.
RX   PubMed=15712272; DOI=10.1002/humu.9313;
RA   Jurkiewicz D., Popowska E., Glaeser C., Hansmann I., Krajewska-Walasek M.;
RT   "Twelve novel JAG1 gene mutations in Polish Alagille syndrome patients.";
RL   Hum. Mutat. 25:321-321(2005).
RN   [29]
RP   VARIANTS ALGS1 22-CYS--ARG-25 DEL; SER-33; VAL-33; ARG-92; TYR-92; PRO-155;
RP   GLY-252; SER-256; ARG-271; SER-504; TYR-693; GLN-889; TYR-911 AND
RP   1055-VAL-ARG-1056 GLY DELINS, AND VARIANT LYS-818.
RX   PubMed=16575836; DOI=10.1002/humu.20310;
RA   Warthen D.M., Moore E.C., Kamath B.M., Morrissette J.J.D., Sanchez P.,
RA   Piccoli D.A., Krantz I.D., Spinner N.B.;
RT   "Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation
RT   detection rate.";
RL   Hum. Mutat. 27:436-443(2006).
RN   [30]
RP   VARIANT ALGS1 TRP-436.
RX   PubMed=23801938; DOI=10.1159/000347231;
RA   Vozzi D., Licastro D., Martelossi S., Athanasakis E., Gasparini P.,
RA   Fabretto A.;
RT   "Alagille Syndrome: A new missense mutation detected by whole-exome
RT   sequencing in a case previously found to be negative by DHPLC and MLPA.";
RL   Mol. Syndromol. 4:207-210(2013).
RN   [31]
RP   VARIANTS SER-664; GLN-937 AND GLN-1104, CHARACTERIZATION OF VARIANTS
RP   SER-664 AND GLN-937, VARIANT TOF LEU-810, CHARACTERIZATION OF VARIANTS TOF
RP   ASP-274 AND LEU-810, CHARACTERIZATION OF VARIANT ALGS1 SER-37,
RP   CHARACTERIZATION OF VARIANT DCHE TYR-234, AND FUNCTION.
RX   PubMed=20437614; DOI=10.1002/humu.21231;
RA   Bauer R.C., Laney A.O., Smith R., Gerfen J., Morrissette J.J.,
RA   Woyciechowski S., Garbarini J., Loomes K.M., Krantz I.D., Urban Z.,
RA   Gelb B.D., Goldmuntz E., Spinner N.B.;
RT   "Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic
RT   stenosis.";
RL   Hum. Mutat. 31:594-601(2010).
CC   -!- FUNCTION: Ligand for multiple Notch receptors and involved in the
CC       mediation of Notch signaling (PubMed:18660822, PubMed:20437614). May be
CC       involved in cell-fate decisions during hematopoiesis (PubMed:9462510).
CC       Seems to be involved in early and late stages of mammalian
CC       cardiovascular development. Inhibits myoblast differentiation (By
CC       similarity). Enhances fibroblast growth factor-induced angiogenesis (in
CC       vitro). {ECO:0000250, ECO:0000269|PubMed:18660822,
CC       ECO:0000269|PubMed:20437614, ECO:0000269|PubMed:9462510}.
CC   -!- SUBUNIT: Interacts with NOTCH2 and NOTCH3 (By similarity). Interacts
CC       with NOTCH1 (in the presence of calcium ions) (PubMed:18660822).
CC       {ECO:0000250|UniProtKB:Q9QXX0, ECO:0000269|PubMed:18660822}.
CC   -!- INTERACTION:
CC       P78504; P15529: CD46; NbExp=5; IntAct=EBI-2847071, EBI-2623451;
CC       P78504; P46531: NOTCH1; NbExp=6; IntAct=EBI-2847071, EBI-636374;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78504-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78504-2; Sequence=VSP_056532;
CC   -!- TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues. In
CC       cervix epithelium expressed in undifferentiated subcolumnar reserve
CC       cells and squamous metaplasia. Expression is up-regulated in cervical
CC       squamous cell carcinoma. Expressed in bone marrow cell line HS-27a
CC       which supports the long-term maintenance of immature progenitor cells.
CC   -!- DEVELOPMENTAL STAGE: Expressed in 32-52 days embryos in the distal
CC       cardiac outflow tract and pulmonary artery, major arteries, portal
CC       vein, optic vesicle, otocyst, branchial arches, metanephros, pancreas,
CC       mesocardium, around the major bronchial branches, and in the neural
CC       tube. {ECO:0000269|PubMed:10978356}.
CC   -!- DOMAIN: The second EGF-like domain is atypical.
CC       {ECO:0000269|PubMed:18660822, ECO:0000269|PubMed:19586525}.
CC   -!- DISEASE: Alagille syndrome 1 (ALGS1) [MIM:118450]: A form of Alagille
CC       syndrome, an autosomal dominant multisystem disorder. It is clinically
CC       defined by hepatic bile duct paucity and cholestasis in association
CC       with cardiac, skeletal, and ophthalmologic manifestations. There are
CC       characteristic facial features and less frequent clinical involvement
CC       of the renal and vascular systems. {ECO:0000269|PubMed:10220506,
CC       ECO:0000269|PubMed:10533065, ECO:0000269|PubMed:11058898,
CC       ECO:0000269|PubMed:11139247, ECO:0000269|PubMed:11157803,
CC       ECO:0000269|PubMed:11180599, ECO:0000269|PubMed:12442286,
CC       ECO:0000269|PubMed:12497640, ECO:0000269|PubMed:15712272,
CC       ECO:0000269|PubMed:16575836, ECO:0000269|PubMed:20437614,
CC       ECO:0000269|PubMed:23801938, ECO:0000269|PubMed:9207788,
CC       ECO:0000269|PubMed:9585603}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart
CC       anomaly which consists of pulmonary stenosis, ventricular septal
CC       defect, dextroposition of the aorta (aorta is on the right side instead
CC       of the left) and hypertrophy of the right ventricle. In this condition,
CC       blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into
CC       the body often causing cyanosis. {ECO:0000269|PubMed:11152664,
CC       ECO:0000269|PubMed:20437614}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Deafness, congenital heart defects, and posterior embryotoxon
CC       (DCHE) [MIM:617992]: An autosomal dominant disease characterized by
CC       mild to severe combined hearing loss, congenital heart defects, and
CC       posterior embryotoxon, a corneal abnormality consisting of a central
CC       collagen core surrounded by a thin layer of Descemets membrane and
CC       separated from the anterior chamber by a layer of endothelium.
CC       Congenital heart defects include tetralogy of Fallot, ventricular
CC       septal defect, or isolated peripheral pulmonic stenosis.
CC       {ECO:0000269|PubMed:12022040, ECO:0000269|PubMed:20437614}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51323.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAG1ID41029ch20p12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF003837; AAC51731.1; -; mRNA.
DR   EMBL; U73936; AAC52020.1; -; mRNA.
DR   EMBL; AF028593; AAB84053.1; -; mRNA.
DR   EMBL; U61276; AAB39007.1; -; mRNA.
DR   EMBL; AK302554; BAG63823.1; -; mRNA.
DR   EMBL; AL035456; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126205; AAI26206.1; -; mRNA.
DR   EMBL; BC126207; AAI26208.1; -; mRNA.
DR   EMBL; U77720; AAC51323.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS13112.1; -. [P78504-1]
DR   RefSeq; NP_000205.1; NM_000214.2. [P78504-1]
DR   RefSeq; XP_016883196.1; XM_017027707.1.
DR   PDB; 2KB9; NMR; -; A=252-295.
DR   PDB; 2VJ2; X-ray; 2.50 A; A/B=185-335.
DR   PDB; 4CBZ; X-ray; 2.50 A; A/B=32-335.
DR   PDB; 4CC0; X-ray; 2.32 A; A/B=32-335.
DR   PDB; 4CC1; X-ray; 2.84 A; A/B=32-335.
DR   PDB; 4XI7; X-ray; 2.05 A; C=1120-1130.
DR   PDB; 5BO1; X-ray; 2.56 A; A/B=186-335.
DR   PDBsum; 2KB9; -.
DR   PDBsum; 2VJ2; -.
DR   PDBsum; 4CBZ; -.
DR   PDBsum; 4CC0; -.
DR   PDBsum; 4CC1; -.
DR   PDBsum; 4XI7; -.
DR   PDBsum; 5BO1; -.
DR   BMRB; P78504; -.
DR   SMR; P78504; -.
DR   BioGRID; 106689; 20.
DR   DIP; DIP-46371N; -.
DR   IntAct; P78504; 17.
DR   STRING; 9606.ENSP00000254958; -.
DR   ChEMBL; CHEMBL3217396; -.
DR   GlyGen; P78504; 9 sites.
DR   iPTMnet; P78504; -.
DR   PhosphoSitePlus; P78504; -.
DR   SwissPalm; P78504; -.
DR   BioMuta; JAG1; -.
DR   DMDM; 20455033; -.
DR   EPD; P78504; -.
DR   jPOST; P78504; -.
DR   MassIVE; P78504; -.
DR   MaxQB; P78504; -.
DR   PaxDb; P78504; -.
DR   PeptideAtlas; P78504; -.
DR   PRIDE; P78504; -.
DR   ProteomicsDB; 5543; -.
DR   ProteomicsDB; 57626; -. [P78504-1]
DR   ABCD; P78504; 10 sequenced antibodies.
DR   Antibodypedia; 4153; 957 antibodies.
DR   DNASU; 182; -.
DR   Ensembl; ENST00000254958; ENSP00000254958; ENSG00000101384. [P78504-1]
DR   GeneID; 182; -.
DR   KEGG; hsa:182; -.
DR   UCSC; uc002wnw.3; human. [P78504-1]
DR   CTD; 182; -.
DR   DisGeNET; 182; -.
DR   GeneCards; JAG1; -.
DR   GeneReviews; JAG1; -.
DR   HGNC; HGNC:6188; JAG1.
DR   HPA; ENSG00000101384; Low tissue specificity.
DR   MalaCards; JAG1; -.
DR   MIM; 118450; phenotype.
DR   MIM; 187500; phenotype.
DR   MIM; 601920; gene.
DR   MIM; 617992; phenotype.
DR   neXtProt; NX_P78504; -.
DR   OpenTargets; ENSG00000101384; -.
DR   Orphanet; 261600; Alagille syndrome due to 20p12 microdeletion.
DR   Orphanet; 261619; Alagille syndrome due to a JAG1 point mutation.
DR   Orphanet; 3303; Tetralogy of Fallot.
DR   PharmGKB; PA29986; -.
DR   VEuPathDB; HostDB:ENSG00000101384; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000160148; -.
DR   HOGENOM; CLU_004732_0_0_1; -.
DR   InParanoid; P78504; -.
DR   OMA; STGFECV; -.
DR   PhylomeDB; P78504; -.
DR   TreeFam; TF351835; -.
DR   PathwayCommons; P78504; -.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2660826; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013700; NOTCH4 Activation and Transmission of Signal to the Nucleus.
DR   SignaLink; P78504; -.
DR   SIGNOR; P78504; -.
DR   BioGRID-ORCS; 182; 16 hits in 962 CRISPR screens.
DR   ChiTaRS; JAG1; human.
DR   EvolutionaryTrace; P78504; -.
DR   GeneWiki; JAG1; -.
DR   GenomeRNAi; 182; -.
DR   Pharos; P78504; Tbio.
DR   PRO; PR:P78504; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P78504; protein.
DR   Bgee; ENSG00000101384; Expressed in oviduct epithelium and 250 other tissues.
DR   ExpressionAtlas; P78504; baseline and differential.
DR   Genevisible; P78504; HS.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; NAS:UniProtKB.
DR   GO; GO:0005112; F:Notch binding; IPI:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; IMP:CAFA.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; NAS:UniProtKB.
DR   GO; GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003180; P:aortic valve morphogenesis; NAS:BHF-UCL.
DR   GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0001709; P:cell fate determination; NAS:UniProtKB.
DR   GO; GO:0061073; P:ciliary body morphogenesis; IEA:Ensembl.
DR   GO; GO:0072017; P:distal tubule development; IEA:Ensembl.
DR   GO; GO:0061444; P:endocardial cushion cell development; ISS:BHF-UCL.
DR   GO; GO:0045446; P:endothelial cell differentiation; NAS:UniProtKB.
DR   GO; GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB.
DR   GO; GO:0030097; P:hemopoiesis; NAS:UniProtKB.
DR   GO; GO:0042491; P:inner ear auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB.
DR   GO; GO:0072070; P:loop of Henle development; IEA:Ensembl.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl.
DR   GO; GO:0045445; P:myoblast differentiation; NAS:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEP:UniProtKB.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0062043; P:positive regulation of cardiac epithelial to mesenchymal transition; ISS:BHF-UCL.
DR   GO; GO:0045639; P:positive regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0061156; P:pulmonary artery morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell population proliferation; NAS:UniProtKB.
DR   GO; GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl.
DR   GO; GO:0002456; P:T cell mediated immunity; IMP:UniProtKB.
DR   DisProt; DP00418; -.
DR   IDEAL; IID00203; -.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR033108; Jag1.
DR   InterPro; IPR026219; Jagged/Serrate.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   InterPro; IPR001007; VWF_dom.
DR   PANTHER; PTHR24049:SF18; PTHR24049:SF18; 3.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 10.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   PRINTS; PR02059; JAGGEDFAMILY.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 16.
DR   SMART; SM00179; EGF_CA; 14.
DR   SMART; SM00214; VWC; 1.
DR   SMART; SM00215; VWC_out; 1.
DR   SUPFAM; SSF57184; SSF57184; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 10.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 16.
DR   PROSITE; PS01186; EGF_2; 12.
DR   PROSITE; PS50026; EGF_3; 15.
DR   PROSITE; PS01187; EGF_CA; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Deafness;
KW   Developmental protein; Disease variant; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Membrane; Notch signaling pathway; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..1218
FT                   /note="Protein jagged-1"
FT                   /id="PRO_0000007625"
FT   TOPO_DOM        34..1067
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1068..1093
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1094..1218
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          185..229
FT                   /note="DSL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DOMAIN          230..263
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          264..294
FT                   /note="EGF-like 2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          296..334
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          336..372
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          374..410
FT                   /note="EGF-like 5; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          412..448
FT                   /note="EGF-like 6; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          450..485
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          487..523
FT                   /note="EGF-like 8; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          525..561
FT                   /note="EGF-like 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          586..627
FT                   /note="EGF-like 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          629..665
FT                   /note="EGF-like 11; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          667..703
FT                   /note="EGF-like 12; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          705..741
FT                   /note="EGF-like 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          744..780
FT                   /note="EGF-like 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          782..818
FT                   /note="EGF-like 15; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          820..856
FT                   /note="EGF-like 16; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          199..207
FT                   /note="Important for interaction with NOTCH1"
FT                   /evidence="ECO:0000269|PubMed:18660822"
FT   REGION          1152..1218
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1152..1169
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1190..1209
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        143
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        217
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        559
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        745
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        960
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        991
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1045
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1064
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        187..196
FT   DISULFID        200..212
FT   DISULFID        220..229
FT   DISULFID        234..245
FT   DISULFID        238..251
FT   DISULFID        253..262
FT   DISULFID        265..276
FT   DISULFID        271..282
FT   DISULFID        284..293
FT   DISULFID        300..312
FT   DISULFID        306..322
FT   DISULFID        324..333
FT   DISULFID        340..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        345..360
FT                   /evidence="ECO:0000250"
FT   DISULFID        362..371
FT                   /evidence="ECO:0000250"
FT   DISULFID        378..389
FT                   /evidence="ECO:0000250"
FT   DISULFID        383..398
FT                   /evidence="ECO:0000250"
FT   DISULFID        400..409
FT                   /evidence="ECO:0000250"
FT   DISULFID        416..427
FT                   /evidence="ECO:0000250"
FT   DISULFID        421..436
FT                   /evidence="ECO:0000250"
FT   DISULFID        438..447
FT                   /evidence="ECO:0000250"
FT   DISULFID        454..464
FT                   /evidence="ECO:0000250"
FT   DISULFID        458..473
FT                   /evidence="ECO:0000250"
FT   DISULFID        475..484
FT                   /evidence="ECO:0000250"
FT   DISULFID        491..502
FT                   /evidence="ECO:0000250"
FT   DISULFID        496..511
FT                   /evidence="ECO:0000250"
FT   DISULFID        513..522
FT                   /evidence="ECO:0000250"
FT   DISULFID        529..540
FT                   /evidence="ECO:0000250"
FT   DISULFID        534..549
FT                   /evidence="ECO:0000250"
FT   DISULFID        551..560
FT                   /evidence="ECO:0000250"
FT   DISULFID        578..605
FT                   /evidence="ECO:0000250"
FT   DISULFID        599..615
FT                   /evidence="ECO:0000250"
FT   DISULFID        617..626
FT                   /evidence="ECO:0000250"
FT   DISULFID        633..644
FT                   /evidence="ECO:0000250"
FT   DISULFID        638..653
FT                   /evidence="ECO:0000250"
FT   DISULFID        655..664
FT                   /evidence="ECO:0000250"
FT   DISULFID        671..682
FT                   /evidence="ECO:0000250"
FT   DISULFID        676..691
FT                   /evidence="ECO:0000250"
FT   DISULFID        693..702
FT                   /evidence="ECO:0000250"
FT   DISULFID        709..720
FT                   /evidence="ECO:0000250"
FT   DISULFID        714..729
FT                   /evidence="ECO:0000250"
FT   DISULFID        731..740
FT                   /evidence="ECO:0000250"
FT   DISULFID        748..759
FT                   /evidence="ECO:0000250"
FT   DISULFID        753..768
FT                   /evidence="ECO:0000250"
FT   DISULFID        770..779
FT                   /evidence="ECO:0000250"
FT   DISULFID        786..797
FT                   /evidence="ECO:0000250"
FT   DISULFID        791..806
FT                   /evidence="ECO:0000250"
FT   DISULFID        808..817
FT                   /evidence="ECO:0000250"
FT   DISULFID        824..835
FT                   /evidence="ECO:0000250"
FT   DISULFID        829..844
FT                   /evidence="ECO:0000250"
FT   DISULFID        846..855
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..159
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056532"
FT   VARIANT         22..25
FT                   /note="Missing (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026296"
FT   VARIANT         31
FT                   /note="A -> V (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026297"
FT   VARIANT         33
FT                   /note="G -> D (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11180599"
FT                   /id="VAR_026298"
FT   VARIANT         33
FT                   /note="G -> S (in ALGS1; dbSNP:rs876661123)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026299"
FT   VARIANT         33
FT                   /note="G -> V (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026300"
FT   VARIANT         37
FT                   /note="L -> S (in ALGS1; the mutant is unable to activate
FT                   Notch signaling; dbSNP:rs121918352)"
FT                   /evidence="ECO:0000269|PubMed:11157803,
FT                   ECO:0000269|PubMed:11180599, ECO:0000269|PubMed:20437614"
FT                   /id="VAR_013186"
FT   VARIANT         39
FT                   /note="I -> S (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12442286"
FT                   /id="VAR_026301"
FT   VARIANT         40
FT                   /note="L -> P (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026302"
FT   VARIANT         45
FT                   /note="V -> L (in biliary atresia; extrahepatic;
FT                   dbSNP:rs183974372)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026303"
FT   VARIANT         53
FT                   /note="N -> D (in biliary atresia; extrahepatic)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026304"
FT   VARIANT         65
FT                   /note="K -> M (in biliary atresia; extrahepatic)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026305"
FT   VARIANT         75
FT                   /note="F -> S (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026306"
FT   VARIANT         78
FT                   /note="C -> S (in ALGS1; dbSNP:rs1555830957)"
FT                   /evidence="ECO:0000269|PubMed:11180599"
FT                   /id="VAR_026307"
FT   VARIANT         79
FT                   /note="L -> H (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013187"
FT   VARIANT         92
FT                   /note="C -> R (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026308"
FT   VARIANT         92
FT                   /note="C -> Y (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026309"
FT   VARIANT         120
FT                   /note="I -> N (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:15712272"
FT                   /id="VAR_026310"
FT   VARIANT         123
FT                   /note="P -> S (in ALGS1; dbSNP:rs1282498658)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026311"
FT   VARIANT         127
FT                   /note="A -> T (in ALGS1; dbSNP:rs930247415)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013188"
FT   VARIANT         129
FT                   /note="P -> R (in ALGS1; dbSNP:rs1032920906)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013189"
FT   VARIANT         146
FT                   /note="V -> I (in dbSNP:rs6040067)"
FT                   /id="VAR_048985"
FT   VARIANT         152
FT                   /note="I -> T (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10533065"
FT                   /id="VAR_013190"
FT   VARIANT         155
FT                   /note="A -> P (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026312"
FT   VARIANT         163
FT                   /note="P -> L (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013191"
FT   VARIANT         163
FT                   /note="P -> R (in ALGS1; dbSNP:rs1555829676)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026313"
FT   VARIANT         181
FT                   /note="Y -> N (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11180599"
FT                   /id="VAR_026314"
FT   VARIANT         184
FT                   /note="R -> C (in ALGS1; dbSNP:rs121918350)"
FT                   /evidence="ECO:0000269|PubMed:9207788,
FT                   ECO:0000269|PubMed:9585603"
FT                   /id="VAR_013192"
FT   VARIANT         184
FT                   /note="R -> G (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013193"
FT   VARIANT         184
FT                   /note="R -> H (in ALGS1; dbSNP:rs121918351)"
FT                   /evidence="ECO:0000269|PubMed:12442286,
FT                   ECO:0000269|PubMed:9585603"
FT                   /id="VAR_013194"
FT   VARIANT         184
FT                   /note="R -> L (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10533065"
FT                   /id="VAR_013195"
FT   VARIANT         187
FT                   /note="C -> S (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013196"
FT   VARIANT         187
FT                   /note="C -> Y (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:15712272"
FT                   /id="VAR_026315"
FT   VARIANT         203
FT                   /note="R -> K (in biliary atresia; extrahepatic)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026316"
FT   VARIANT         220
FT                   /note="C -> F (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11139247"
FT                   /id="VAR_013197"
FT   VARIANT         224
FT                   /note="W -> C (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026317"
FT   VARIANT         229
FT                   /note="C -> G (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013198"
FT   VARIANT         229
FT                   /note="C -> Y (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11058898"
FT                   /id="VAR_013199"
FT   VARIANT         234
FT                   /note="C -> Y (in DCHE; the mutant is unable to activate
FT                   Notch signaling; dbSNP:rs121918353)"
FT                   /evidence="ECO:0000269|PubMed:12022040,
FT                   ECO:0000269|PubMed:20437614"
FT                   /id="VAR_026318"
FT   VARIANT         252
FT                   /note="R -> G (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026319"
FT   VARIANT         256
FT                   /note="G -> S (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026320"
FT   VARIANT         269
FT                   /note="P -> L (in ALGS1; dbSNP:rs797044956)"
FT                   /evidence="ECO:0000269|PubMed:12497640"
FT                   /id="VAR_026321"
FT   VARIANT         271
FT                   /note="C -> R (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026322"
FT   VARIANT         274
FT                   /note="G -> D (in TOF; temperature sensitive mutation; the
FT                   protein is abnormally glycosylated and retained
FT                   intracellularly; unable to activate Notch signaling;
FT                   dbSNP:rs28939668)"
FT                   /evidence="ECO:0000269|PubMed:11152664,
FT                   ECO:0000269|PubMed:12649809, ECO:0000269|PubMed:20437614"
FT                   /id="VAR_013200"
FT   VARIANT         284
FT                   /note="C -> F (in ALGS1; dbSNP:rs1555829067)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013201"
FT   VARIANT         288
FT                   /note="W -> C (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013202"
FT   VARIANT         386
FT                   /note="G -> R (in ALGS1; dbSNP:rs863223650)"
FT                   /evidence="ECO:0000269|PubMed:11058898"
FT                   /id="VAR_013203"
FT   VARIANT         436
FT                   /note="C -> W (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:23801938"
FT                   /id="VAR_071513"
FT   VARIANT         438
FT                   /note="C -> F (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013204"
FT   VARIANT         504
FT                   /note="N -> S (in ALGS1; dbSNP:rs527236046)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026323"
FT   VARIANT         664
FT                   /note="C -> S (found in a patient with pulmonary stenosis;
FT                   unknown pathological significance; the mutant is able to
FT                   activate Notch signaling)"
FT                   /evidence="ECO:0000269|PubMed:20437614"
FT                   /id="VAR_080875"
FT   VARIANT         690
FT                   /note="Y -> D (in biliary atresia; extrahepatic)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026324"
FT   VARIANT         693
FT                   /note="C -> Y (in ALGS1; dbSNP:rs566563238)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026325"
FT   VARIANT         714
FT                   /note="C -> Y (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11180599"
FT                   /id="VAR_026326"
FT   VARIANT         731
FT                   /note="C -> S (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013205"
FT   VARIANT         740
FT                   /note="C -> R (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:10220506"
FT                   /id="VAR_013206"
FT   VARIANT         753
FT                   /note="C -> R (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:11139247"
FT                   /id="VAR_013207"
FT   VARIANT         810
FT                   /note="P -> L (in TOF; the mutant is unable to activate
FT                   Notch signaling; dbSNP:rs769531968)"
FT                   /evidence="ECO:0000269|PubMed:20437614"
FT                   /id="VAR_080876"
FT   VARIANT         818
FT                   /note="R -> K"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026327"
FT   VARIANT         871
FT                   /note="P -> R (in biliary atresia; extrahepatic;
FT                   dbSNP:rs35761929)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026328"
FT   VARIANT         889
FT                   /note="R -> Q (in ALGS1; unknown pathological significance;
FT                   dbSNP:rs149419694)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026329"
FT   VARIANT         902
FT                   /note="C -> S (in ALGS1; dbSNP:rs876661122)"
FT                   /evidence="ECO:0000269|PubMed:11180599"
FT                   /id="VAR_026330"
FT   VARIANT         908
FT                   /note="H -> Q (in biliary atresia; extrahepatic)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026331"
FT   VARIANT         911
FT                   /note="C -> Y (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:16575836"
FT                   /id="VAR_026332"
FT   VARIANT         913
FT                   /note="S -> R (in ALGS1)"
FT                   /evidence="ECO:0000269|PubMed:12442286"
FT                   /id="VAR_026333"
FT   VARIANT         921
FT                   /note="L -> P (in biliary atresia; extrahepatic;
FT                   dbSNP:rs1305578649)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026334"
FT   VARIANT         937
FT                   /note="R -> Q (likely benign variant; the mutant is able to
FT                   activate Notch signaling; dbSNP:rs145895196)"
FT                   /evidence="ECO:0000269|PubMed:12497640,
FT                   ECO:0000269|PubMed:20437614"
FT                   /id="VAR_026335"
FT   VARIANT         1055..1056
FT                   /note="VR -> G (in ALGS1)"
FT                   /id="VAR_026336"
FT   VARIANT         1104
FT                   /note="H -> Q (found in patient with tetralogy of Fallot
FT                   and pulmonary stenosis; unknown pathological significance;
FT                   dbSNP:rs1250645531)"
FT                   /evidence="ECO:0000269|PubMed:20437614"
FT                   /id="VAR_080877"
FT   VARIANT         1213
FT                   /note="R -> Q (in biliary atresia; extrahepatic;
FT                   dbSNP:rs138007561)"
FT                   /evidence="ECO:0000269|PubMed:12297837"
FT                   /id="VAR_026337"
FT   MUTAGEN         207
FT                   /note="F->A: Strongly reduced NOTCH1 binding."
FT                   /evidence="ECO:0000269|PubMed:18660822"
FT   CONFLICT        117
FT                   /note="R -> P (in Ref. 5; AAB39007)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="P -> R (in Ref. 1; AAC51731)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        498
FT                   /note="N -> D (in Ref. 1; AAC51731)"
FT                   /evidence="ECO:0000305"
FT   STRAND          33..43
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          52..57
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   TURN            61..63
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          73..81
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          118..124
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          130..140
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          143..147
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          150..160
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          163..172
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          174..187
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   TURN            193..196
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          203..205
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          208..212
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   TURN            226..229
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   TURN            240..242
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          257..259
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   TURN            268..270
FT                   /evidence="ECO:0007829|PDB:2KB9"
FT   STRAND          273..275
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          277..280
FT                   /evidence="ECO:0007829|PDB:2KB9"
FT   STRAND          286..289
FT                   /evidence="ECO:0007829|PDB:2KB9"
FT   TURN            290..293
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          295..297
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   HELIX           299..303
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          311..316
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          319..323
FT                   /evidence="ECO:0007829|PDB:4CC0"
FT   STRAND          328..330
FT                   /evidence="ECO:0007829|PDB:4CC0"
SQ   SEQUENCE   1218 AA;  133799 MW;  F36EE9FBF64DF162 CRC64;
     MRSPRTRGRS GRPLSLLLAL LCALRAKVCG ASGQFELEIL SMQNVNGELQ NGNCCGGARN
     PGDRKCTRDE CDTYFKVCLK EYQSRVTAGG PCSFGSGSTP VIGGNTFNLK ASRGNDRNRI
     VLPFSFAWPR SYTLLVEAWD SSNDTVQPDS IIEKASHSGM INPSRQWQTL KQNTGVAHFE
     YQIRVTCDDY YYGFGCNKFC RPRDDFFGHY ACDQNGNKTC MEGWMGPECN RAICRQGCSP
     KHGSCKLPGD CRCQYGWQGL YCDKCIPHPG CVHGICNEPW QCLCETNWGG QLCDKDLNYC
     GTHQPCLNGG TCSNTGPDKY QCSCPEGYSG PNCEIAEHAC LSDPCHNRGS CKETSLGFEC
     ECSPGWTGPT CSTNIDDCSP NNCSHGGTCQ DLVNGFKCVC PPQWTGKTCQ LDANECEAKP
     CVNAKSCKNL IASYYCDCLP GWMGQNCDIN INDCLGQCQN DASCRDLVNG YRCICPPGYA
     GDHCERDIDE CASNPCLNGG HCQNEINRFQ CLCPTGFSGN LCQLDIDYCE PNPCQNGAQC
     YNRASDYFCK CPEDYEGKNC SHLKDHCRTT PCEVIDSCTV AMASNDTPEG VRYISSNVCG
     PHGKCKSQSG GKFTCDCNKG FTGTYCHENI NDCESNPCRN GGTCIDGVNS YKCICSDGWE
     GAYCETNIND CSQNPCHNGG TCRDLVNDFY CDCKNGWKGK TCHSRDSQCD EATCNNGGTC
     YDEGDAFKCM CPGGWEGTTC NIARNSSCLP NPCHNGGTCV VNGESFTCVC KEGWEGPICA
     QNTNDCSPHP CYNSGTCVDG DNWYRCECAP GFAGPDCRIN INECQSSPCA FGATCVDEIN
     GYRCVCPPGH SGAKCQEVSG RPCITMGSVI PDGAKWDDDC NTCQCLNGRI ACSKVWCGPR
     PCLLHKGHSE CPSGQSCIPI LDDQCFVHPC TGVGECRSSS LQPVKTKCTS DSYYQDNCAN
     ITFTFNKEMM SPGLTTEHIC SELRNLNILK NVSAEYSIYI ACEPSPSANN EIHVAISAED
     IRDDGNPIKE ITDKIIDLVS KRDGNSSLIA AVAEVRVQRR PLKNRTDFLV PLLSSVLTVA
     WICCLVTAFY WCLRKRRKPG SHTHSASEDN TTNNVREQLN QIKNPIEKHG ANTVPIKDYE
     NKNSKMSKIR THNSEVEEDD MDKHQQKARF AKQPAYTLVD REEKPPNGTP TKHPNWTNKQ
     DNRDLESAQS LNRMEYIV
//
DBGET integrated database retrieval system